| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 787 | 1.514 | 4.053 | 587 | 561 | 1.854 | 3.267 | 6.252 | 6.567 | 7.297 |
| Total Income - EUR | 38.650 | 1.514 | 4.053 | 587 | 561 | 1.858 | 3.317 | 6.440 | 6.567 | 7.297 |
| Total Expenses - EUR | 2.985 | 946 | 3.897 | 3.938 | 2.041 | 4.963 | 12.157 | 6.028 | 6.484 | 7.212 |
| Gross Profit/Loss - EUR | 35.665 | 568 | 156 | -3.351 | -1.481 | -3.105 | -8.840 | 412 | 84 | 85 |
| Net Profit/Loss - EUR | 35.641 | 523 | 34 | -3.369 | -1.497 | -3.161 | -8.939 | 224 | 70 | 71 |
| Employees | 3 | 3 | 1 | 4 | 0 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Obs-Gin-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 54.215 | 53.004 | 51.149 | 48.009 | 46.552 | 47.703 | 45.339 | 44.934 | 44.632 | 75.037 |
| Current Assets | 978 | 896 | 83 | 335 | 140 | 408 | 421 | 2.703 | 1.058 | 1.834 |
| Inventories | 0 | 0 | 0 | 64 | 63 | 62 | 253 | 254 | 363 | 1.020 |
| Receivables | 0 | 0 | 0 | 6 | 51 | 7 | 6 | 6 | 0 | 0 |
| Cash | 978 | 896 | 83 | 265 | 25 | 340 | 162 | 2.443 | 695 | 814 |
| Shareholders Funds | 34.041 | 35.171 | 34.611 | 30.606 | 28.516 | 24.814 | 15.326 | 15.597 | 15.621 | 15.605 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 21.152 | 18.729 | 16.622 | 17.738 | 18.175 | 23.297 | 30.434 | 32.039 | 36.190 | 67.268 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8710
|
|||||||||
Comments - Obs-Gin-Med Srl